Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo

BACKGROUND/AIMS: The success of sorafenib in the treatment of advanced hepatocellular carcinoma (HCC) has focused interest on the role of Ras signaling in this malignancy. We investigated the molecular alterations of the Ras pathway in HCC and the antineoplastic effects of sorafenib in combination w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Newell, Pippa, Toffanin, Sara, Villanueva, Augusto, Chiang, Derek Y., Minguez, Beatriz, Cabellos, Laia, Savic, Radoslav, Hoshida, Yujin, Lim, Kiat Hon, Melgar-Lesmes, Pedro, Yea, Steven, Peix, Judit, Deniz, Kemal, Fiel, M. Isabel, Thung, Swan, Alsinet, Clara, Tovar, Victoria, Mazzaferro, Vincenzo, Bruix, Jordi, Roayaie, Sasan, Schwartz, Myron, Friedman, Scott L., Llovet, Josep M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2970800/
https://ncbi.nlm.nih.gov/pubmed/19665249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2009.03.028
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados